CTSA K12 Program at Virginia Commonwealth University

弗吉尼亚联邦大学 CTSA K12 项目

基本信息

项目摘要

The COVID-19 pandemic highlighted the critical importance of translational research to eradicate human disease, tackle emerging public health threats and promote health, especially in hard-to-reach communities that face health disparities. To take on these challenges, we need a diverse, well-resourced, and well-trained research workforce, as highlighted by the NIH Physician-Scientist Workforce report. 1 The VCU Wright Regional Center for Clinical and Translational Science (Wright Regional CCTS) serves a region in Central and Eastern Virginia and North Carolina that includes both rural and urban underserved communities and has vast experience serving a diverse community of patients who often face health disparities. The nature of our environment has driven the development of a research workforce that is prepared to meet the challenge of engaging and serving diverse patients. The Wright Regional CCTS serves as the hub for providing the translational research infrastructure for the training and career development of scholars through their professional life cycle. In addition, The Wright Center CCTS has a $32 million endowment with which we have established the first Wright Faculty Scholars in Health Disparities program. This program supports early career faculty from diverse backgrounds who are committed to better understanding the drivers and developing solutions to health inequities in our communities. Our existing partner institutions bring experience training the workforce across the translational spectrum with an emphasis on community engaged research (Eastern Virginia Medical School (EVMS)), informatics (Old Dominion University (ODU)) and mentorship (Virginia State University (VSU), an HBCU). Training scholars to translate research observations to clinical application in our unique communities is a priority for the proposed K12 Training Program. Our program will continue its commitment to providing early career faculty/late-stage postdoctoral fellows with a comprehensive “blueprint” for transitioning to research independence. We will recruit scholars from a pool of early career scientists who are diverse in both research discipline and demographics. Through integration with our UM1 and RC2 awards, K12 scholars will be exposed to an innovative and comprehensive program that supports 75% committed time to scholar specific domain expertise but also provides a combination of didactic, virtual, and experiential training in fundamental characteristics of the translational scientist. We will achieve our goals through the following specific aims: Aim 1: Prepare early career translational researchers for research independence through comprehensive, innovative, and individualized training in translational science. K12 scholars will be positioned to translate preclinical, clinical, and community-based research to improving health of all communities. Aim 2: Serve as an institutional resource for research career development and facilitate the creation of a diverse community of clinical and translational researchers through both internal and external partnerships.
COVID-19 大流行凸显了转化研究对于根除人类疾病的至关重要性。 疾病,应对新出现的公共卫生威胁并促进健康,特别是在难以到达的社区 为了应对这些挑战,我们需要多元化、资源充足和训练有素的人才。 正如 NIH 医师科学家劳动力报告 1 弗吉尼亚联邦大学赖特地区研究人员所强调的那样。 临床和转化科学中心(赖特地区 CCTS)为中部和东部地区提供服务 弗吉尼亚州和北卡罗来纳州,包括农村和城市服务不足的社区,拥有丰富的经验 为经常面临健康差异的多元化患者群体提供服务 我们环境的性质已经改变了这一点。 推动了研究队伍的发展,准备迎接参与和服务的挑战 赖特地区 CCTS 是提供转化研究的中心。 此外,为学者的职业生命周期提供培训和职业发展的基础设施。 莱特中心 CCTS 拥有 3200 万美元的捐赠,我们用它建立了第一个莱特学院 健康差异学者计划该计划支持来自不同背景的早期职业教师。 他们致力于更好地了解驱动因素并制定解决方案来解决我们的健康不平等问题 我们现有的合作伙伴机构带来了培训劳动力的经验。 重点是社区参与研究(东弗吉尼亚医学院(EVMS)), 信息学(旧道明大学(ODU))和导师(弗吉尼亚州立大学(VSU),HBCU)。 培训学者以我们独特的方式将研究观察转化为临床应用 社区是拟议的 K12 培训计划的优先事项,我们的计划将继续其承诺。 为早期职业教师/后期博士后研究员提供全面的过渡“蓝图” 为了研究的独立性,我们将从一批早期职业科学家中招募学者,他们在这两个方面都具有多样性。 通过与我们的 UM1 和 RC2 奖项整合,K12 学者将 接触创新和全面的计划,支持 75% 的学术时间 特定领域的专业知识,还提供教学、虚拟和体验式培训的结合 转化科学家的基本特征。 我们将通过以下具体目标来实现我们的目标: 目标 1:通过全面的、 K12 学者将被定位于翻译。 临床前、临床和社区研究,以改善所有社区的健康。 目标 2:作为研究职业发展的机构资源并促进创建多元化的人才 通过内部和外部合作伙伴关系的临床和转化研究人员社区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SERGE PATRICK NANASINKAM其他文献

SERGE PATRICK NANASINKAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SERGE PATRICK NANASINKAM', 18)}}的其他基金

Project 1: Lung Cancer
项目一:肺癌
  • 批准号:
    10493289
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
Project 1: Lung Cancer
项目一:肺癌
  • 批准号:
    10290161
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    9913602
  • 财政年份:
    2018
  • 资助金额:
    $ 74.95万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    10409658
  • 财政年份:
    2018
  • 资助金额:
    $ 74.95万
  • 项目类别:
MicroRNA Expression in Lung Cancer Development and Progression
肺癌发生和进展中的 MicroRNA 表达
  • 批准号:
    8021770
  • 财政年份:
    2010
  • 资助金额:
    $ 74.95万
  • 项目类别:
MicroRNA Expression in Lung Cancer Development and Progression
肺癌发生和进展中的 MicroRNA 表达
  • 批准号:
    7873350
  • 财政年份:
    2010
  • 资助金额:
    $ 74.95万
  • 项目类别:
Integration of transcriptosome and microRNome in Understanding COPD Phenotypes
转录体和 microRNome 的整合在理解 COPD 表型中的作用
  • 批准号:
    7690864
  • 财政年份:
    2008
  • 资助金额:
    $ 74.95万
  • 项目类别:
Regulation of Prostacyclin in Pulmonary Hypertension
前列环素在肺动脉高压中的调节
  • 批准号:
    6817114
  • 财政年份:
    2004
  • 资助金额:
    $ 74.95万
  • 项目类别:
Regulation of Prostacyclin in Pulmonary Hypertension
前列环素在肺动脉高压中的调节
  • 批准号:
    6933068
  • 财政年份:
    2004
  • 资助金额:
    $ 74.95万
  • 项目类别:
Regulation of Prostacyclin in Pulmonary Hypertension
前列环素在肺动脉高压中的调节
  • 批准号:
    7106518
  • 财政年份:
    2004
  • 资助金额:
    $ 74.95万
  • 项目类别:

相似海外基金

Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
  • 批准号:
    10722194
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
2023 Collagen Gordon Research Conference and Seminar
2023年胶原蛋白戈登研究会议暨研讨会
  • 批准号:
    10675849
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
Virtual Care Coordination in VA Primary Care-Mental Health Integration
退伍军人事务部初级保健-心理健康一体化中的虚拟护理协调
  • 批准号:
    10639607
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
Improving access to opioid use disorder treatment among marginalized patients with a tailored telehealth intervention
通过量身定制的远程医疗干预措施,改善边缘化患者获得阿片类药物使用障碍治疗的机会
  • 批准号:
    10739650
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了